More intriguing is the fact that a mutation in UPF1 (NMD factor) has been reported as a driver mutation in two different types of cancers: Inflammatory Myofibroblastic Tumors (benign tumor) [36] and in Pancreatic Adenosquamous Carcinoma [39]. Here, UPF1 is linked to inflammatory myofibroblastic tumor.